Publications

5491 Results

Change in RECIST Tumor Size Correlates Linearly with Survival in Patients Treated with Checkpoint Inhibitor Therapy (SWOG S1609)

Authors
M Othus;S Patel;Y Chae;E Dietrich;H Streicher;E Sharon;R Kurzrock
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 2504); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), oral
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Desmoid Tumors (Cohort 27)

Authors
YK Chae;M Othus;S Patel;B Powers;C-T Hsueh;R Govindarajan;S Bucur;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 11516); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Vulvar Cancers

Authors
Y Chae;M Othus;S Patel;R Edwards;J Scalici;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 5517); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) (SWOG S1802)

Authors
Bsteh;J Buckley;D Ostrow;J Parmentier;S Maganti;S Mitchell;S Sadis;J Smith;J Ni;X Peng;M Plets;C Tangen;A Aparicio;B Chapin;D Quinn;D McConkey;T Dorff;I Thompson;T Triche;A Goldkorn
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 5036); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S1802

A phase III randomized trial of eribulin (E) with or without gemcitabine vs standard of care (SOC) for metastatic urothelial carcinoma (UC) refractory to or ineligible for PD/PDL1 antibody (Ab): SWOG S1937

Authors
S Sadeghi;M Plets;P Lara;C Tangen;R Bangs;S Lerner;T Flaig;D Petrylak;I Thompson
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr TPS4608); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), tips, poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S1937

A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000 (NCT# 04511013)

Authors
Z Eroglu;J Moon;H Tawbi;Y Najjar;R Kotecha;V Spektor;M Wu;E Sharon;J Wolchok;S Patel
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr TPS9603); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), TIP poster session
Year
2023
Research Committee(s)
Melanoma
Study Number(s)
S2000

Rural cancer care delivery during the COVID-19 pandemic for patients with early-stage cancer

Authors
I Okado;M Liu;C Elhajj;L Wilkens;R Holcombe
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr e18566); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), publication only
Year
2023
Research Committee(s)
Cancer Care Delivery

The Association of Sociodemographic Variables with Smoking Prevalence in Patients Enrolled on Clinical Trials

Authors
C Preasant;R Vaidya;C Till;K Ashing;G Warren;D Hershman;V Sun;S Subbiah;R Salgia;E Massarelli;J Mortimer;M Fakih;S Pal;A Amini;L Erhunmwsee;T Phillips;S Rosen;J Unger
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr e13595); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), publication only
Year
2023
Research Committee(s)
Cancer Care Delivery

Association of Baseline Measures of Socioeconomic Deprivation and Healthcare Utilization in Patients Enrolled in SWOG Cancer Clinical Trials

Authors
D Hershman;R Vaidya;C Till;W Barlow;M LeBlanc;S Ramsey;J Unger
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 6527); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Cancer Care Delivery

SWOG S1823/CCTG GCC1 - Translational Observational Investigational Study of the Liquid Biomarker microRNA 371a-3p in Newly Diagnosed Germ Cell Tumours - Real-World Trial Design, Rapid Accrual, and Robust Secondary Use of Data Opportunities

Authors
A Morin Coulombe;G Ozgun;R Johnson;M Lewis;N Adra;S Eggener;B Roth;C Ryan;C Porter;F Millard;T Jang;R Hamilton;L Einhorn;C Kollmannsberger;K Arnold;C Blanke;S Daneshmand;C Nichols;L Nappi;A Harzstark
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr TPS5103); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), TIP poster session
Year
2023
Research Committee(s)
Genitourinary and Prevention and Epidemiology
Study Number(s)
S1823